Table 2.
Univariate and multivariate analysis of prognostic parameters for survival in patients with GC
| Prognostic parameter | Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|---|
| HR (95% CI) | p value | HR (95% CI) | p value | ||
| Expression of ITGBL1 (low vs. high) | 2.728 (1.576-4.724) | <0.001 | 2.094(1.184-3.703) | 0.011 | |
| Age (< 60 vs. ≥ 60) | 1.013 (0.998-1.028) | 0.083 | - | - | |
| Gender (male vs. female) | 0.918 (0.649-1.299) | 0.631 | - | - | |
| Lauren type (intestinal vs. diffuse) | 2.257 (1.625-3.134) | <0.001 | 1.340 (0.850-2.112) | 0.208 | |
| Tumor size (≤ 5 cm vs. > 5 cm) | 3.665 (2.576-5.215) | <0.001 | 1.314 0.796-2.168) | 0.295 | |
| T classification (T1, 2 vs. T3, 4) | 8.497 (4.703-15.353) | <0.001 | 1.379 (0.395-4.819) | 0.614 | |
| Lymph node metastasis (absent vs. present) | 7.771 (4.737-12.750) | <0.001 | 3.323 (0.916-12.056) | 0.068 | |
| TNM stage (I - II vs. III - IV) | 9.135 (5.879-14.193) | <0.001 | 1.562 (0.371-6.575) | 0.543 | |
| Early gastric cancer (no vs. yes) | 14.973 (4.771-46.992) | <0.001 | 4.491 (0.510-39.517) | 0.176 | |
| Distant metastasis (absent vs. present) | 9.667 (6.331-14.761) | <0.001 | 5.229 (2.861-9.557) | <0.001 |
aHR: Hazard ratio; CI: Confidence interval
bThe bold number represents the p value with significant differences